In vivo detection of inducible nitric oxide synthase in rodent gliomas.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Free Radical Biology & Medicine

• Publication date

  2010-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.freeradbiomed.2009.12.012PMID 20034558
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Phenyl-tert-butylnitrone induces tumor regression and decreases angiogenesis in a C6 rat glioma model.

  2008cited by this paper
• Adenosine rescues glioma cells from cytokine-induced death by interfering with the signaling network involved in nitric oxide production.

  2008cited by this paper
• In vivo spin trapping of nitric oxide from animal tumors.

  2007cited by this paper
• In Vivo Detection of c-MET Expression in a Rat Hepatocarcinogenesis Model Using Molecularly Targeted Magnetic Resonance Imaging

  2007cited by this paper
• In vivo detection of c-Met expression in a rat C6 glioma model

  2007cited by this paper
• Postimmunization with IFN-γ-Secreting Glioma Cells Combined with the Inducible Nitric Oxide Synthase Inhibitor Mercaptoethylguanidine Prolongs Survival of Rats with Intracerebral Tumors1

  2007cited by this paper
• Nitric Oxide and Cancer Development

  2007cited by this paper
• Expression of HIF-1alpha and iNOS in astrocytic gliomas: a clinicopathological study.

  2006cited by this paper
• Visualization of nitric oxide in living cells by a copper-based fluorescent probe

  2006cited by this paper
• Pitfalls in the diagnosis of brain tumours.

  2006cited by this paper
• Reduced Glioma Infiltration in Src-deficient Mice

  2006cited by this paper
• High-grade and low-grade gliomas: differentiation by using perfusion MR imaging.

  2005cited by this paper
• Visualizing inducible nitric-oxide synthase in living cells with a heme-binding fluorescent inhibitor.

  2005cited by this paper
• Tissue factor-dependent coagulation is preferentially up-regulated within arterial branching areas in a baboon model of Escherichia coli sepsis.

  2005cited by this paper
• Use of magnetic resonance imaging to assess blood-brain/blood-glioma barrier opening during conformal radiotherapy.

  2005cited by this paper
• The RG2 rat glioma model

  2005cited by this paper
• Monomeric inducible nitric oxide synthase localizes to peroxisomes in hepatocytes.

  2005cited by this paper
• Rat brain tumor models in experimental neuro-oncology:The 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 Gliomas

  2004cited by this paper
• Volume Reconstruction Techniques Improve the Correlation Between Histological and in vivo Tumor Volume Measurements in Mouse Models of Human Gliomas

  2004cited by this paper
• Molecular changes in gliomas

  2004cited by this paper
• Molecular Mechanisms of Glioma Cell Migration and Invasion

  2004cited by this paper
• Glioblastoma cells release factors that disrupt blood-brain barrier features

  2004cited by this paper
• Impact of morphology and biology on the prognosis of patients with gliomas.

  2004cited by this paper
• Altered molecular pathways in gliomas: an overview of clinically relevant issues.

  2004cited by this paper
• Models for neuro-oncological preclinical studies: solid orthotopic and heterotopic grafts of human gliomas into nude mice.

  2003cited by this paper
• Magnetic resonance imaging of patched heterozygous and xenografted mouse brain tumors

  2003cited by this paper
• Magnetic resonance molecular imaging of the HER-2/neu receptor.

  2003cited by this paper
• Molecular mechanisms underlying dexamethasone inhibition of iNOS expression and activity in C6 glioma cells

  2003cited by this paper
• Albumin‐binding MR blood pool agents as MRI contrast agents in an intracranial mouse glioma model

  2003cited by this paper
• Characterization of the Expression of Inducible Nitric Oxide Synthase in Rat and Human Liver During Hemorrhagic Shock

  2003cited by this paper
• Antiangiogenic effects of dexamethasone in 9L gliosarcoma assessed by MRI cerebral blood volume maps.

  2003cited by this paper
• Pathodynamics of nitric oxide production within implanted glioma studied with an in vivo microdialysis technique and immunohistochemistry.

  2003cited by this paper
• VRIJEDNOST PREVENCIJE PRIROĐENOG IIŠČAŠENJA KUKA OD HIPOKRATA DO DANAS

  2003cited by this paper
• MRI and fluorescence microscopy of the acute vascular response to VEGF165: vasodilation, hyper‐permeability and lymphatic uptake, followed by rapid inactivation of the growth factor

  2002cited by this paper
• Peroxisomal localization of inducible nitric oxide synthase in hepatocytes

  2002cited by this paper
• The role of nitric oxide in cancer

  2002cited by this paper
• Glioma tumourgenicity is decreased by iNOS knockout: experimental studies using the C6 striatal implantation glioma model

  2002cited by this paper
• Development of a rat C6 brain tumor model.

  2002cited by this paper
• Antivasculature effects of doxorubicin-containing liposomes in an intracranial rat brain tumor model.

  2002cited by this paper
• Vascular‐targeted molecular imaging using functionalized polymerized vesicles

  2002cited by this paper
• Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasion

  2002cited by this paper
• Correlation between bradykinin-induced blood–tumor barrier permeability and B2 receptor expression in experimental brain tumors

  2001cited by this paper
• Magnetic Resonance Imaging of Ethyl-nitrosourea-induced Rat Gliomas: A Model for Experimental Therapeutics of Low-grade Gliomas

  2001cited by this paper
• Specific targeting of folate–dendrimer MRI contrast agents to the high affinity folate receptor expressed in ovarian tumor xenografts

  2001cited by this paper
• Identification of residues critical for enzymatic activity in the domain encoded by exons 8 and 9 of the human inducible nitric oxide synthase.

  2001cited by this paper
• The effects of chronic nitric oxide synthase suppression on glioma pathophysiology.

  2000cited by this paper
• RESPONSE: Re: Brain and Other Central Nervous System Cancers: Recent Trends in Incidence and Mortality.

  1999cited by this paper
• Cancer surveillance series [corrected]: brain and other central nervous system cancers: recent trends in incidence and mortality.

  1999cited by this paper
• RESPONSE: re: brain and other central nervous system cancers: recent trends in incidence and mortality

  1999cited by this paper
• Role of nitric oxide in tumor progression: Lessons from experimental tumors

  1998cited by this paper
• Significance of nitric oxide in carcinogenesis, tumor progression and cancer therapy

  1998cited by this paper
• Detection of tumor angiogenesis in vivo by αvβ3-targeted magnetic resonance imaging

  1998cited by this paper
• Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging.

  1998cited by this paper
• Effects of nitric oxide modulation on tumour blood flow and microvascular permeability in C6 glioma

  1998cited by this paper
• Vesicle membrane association of nitric oxide synthase in primary mouse macrophages.

  1995cited by this paper
• Expression of nitric oxide synthase in human central nervous system tumors.

  1995cited by this paper
• A molecular receptor-binding contrast agent for magnetic resonance imaging of the liver.

  1995cited by this paper
• Nitric oxide: a physiologic messenger molecule.

  1994cited by this paper
• Magnetic resonance imaging of perfusion using spin inversion of arterial water

  1992cited by this paper
• Nitric oxide: physiology, pathophysiology, and pharmacology.

  1991cited by this paper
• Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

  1987cited by this paper
• What is the Correct Value for the Brain-Blood Partition Coefficient for Water?

  1985cited by this paper

• Temporary opening of the blood-brain barrier with the nitrone compound OKN-007.

  2021cites this paper
• In vivo and ex vivo assessment of bladder hyper-permeability and using molecular targeted magnetic resonance imaging to detect claudin-2 in a mouse model for interstitial cystitis

  2020cites this paper
• Computed Tomography and Magnetic Resonance Imaging.

  2020cites this paper
• Assessment of an scFv Antibody Fragment Against ELTD1 in a G55 Glioblastoma Xenograft Model

  2020cites this paper
• Assessing bladder hyper-permeability biomarkers in vivo using molecularly-targeted MRI.

  2020cites this paper
• Cerebral inducible nitric oxide synthase protein expression in microglia, astrocytes and neurons in Trypanosoma brucei brucei-infected rats

  2019cites this paper
• Optimized monoclonal antibody treatment against ELTD1 for GBM in a G55 xenograft mouse model

  2019cites this paper
• Targeting ELTD1, an angiogenesis marker for glioblastoma (GBM), also affects VEGFR2: molecular-targeted MRI assessment.

  2019cites this paper
• Elevation of the TP53 isoform Δ133p53β in glioblastomas: an alternative to mutant p53 in promoting tumor development

  2018cites this paper
• Chapter 13 – Application of MRI to Study the Role of Nitric Oxide in Cancer Therapy

  2017cites this paper
• NOS Expression and NO Function in Glioma and Implications for Patient Therapies

  2017cites this paper
• In vivo targeted molecular magnetic resonance imaging of free radicals in diabetic cardiomyopathy within mice

  2015cites this paper
• Molecular MRI differentiation of VEGF receptor-2 levels in C6 and RG2 glioma models.

  2013influential citation
• Endothelial hypoxic metabolism in carcinogenesis and dissemination : HIF-A isoforms are a NO metastatic phenomenon

  2013cites this paper
• The prospective application of a hypoxic radiosensitizer, doranidazole to rat intracranial glioblastoma with blood brain barrier disruption

  2013cites this paper
• ELTD1, a potential new biomarker for gliomas.

  2013cites this paper
• In vivo detection of free radicals in mouse septic encephalopathy using molecular MRI and immuno-spin trapping.

  2013cites this paper
• Regression of glioma tumor growth in F98 and U87 rat glioma models by the Nitrone OKN-007.

  2013cites this paper
• Computed tomography and magnetic resonance imaging.

  2013cites this paper
• In vivo detection of free radicals using molecular MRI and immuno-spin trapping in a mouse model for amyotrophic lateral sclerosis.

  2013cites this paper
• Nitrone-based therapeutics for neurodegenerative diseases: their use alone or in combination with lanthionines.

  2013cites this paper
• Combined molecular MRI and immuno-spin-trapping for in vivo detection of free radicals in orthotopic mouse GL261 gliomas.

  2013cites this paper
• In Vivo Imaging of Immuno-Spin Trapped Radicals With Molecular Magnetic Resonance Imaging in a Diabetic Mouse Model

  2012cites this paper
• Dual peptide nucleic acid- and peptide-functionalized shell cross-linked nanoparticles designed to target mRNA toward the diagnosis and treatment of acute lung injury.

  2012cites this paper
• In Vivo Imaging of Immunospin-Trapped Radicals With Molecular Magnetic Resonance Imaging in a Mouse Diabetes Model

  2012cites this paper
• Cerebral Cavernous Malformations: Advanced Magnetic Resonance Imaging

  2011cites this paper
• Assessment of Rodent Glioma Models Using Magnetic Resonance Imaging Techniques

  2011cites this paper
• Adrenomedullin and nitric oxide: implications for the etiology and treatment of primary brain tumors.

  2011cites this paper
• Effects of PBN and OKN007 in rodent glioma models assessed by 1H MR spectroscopy.

  2011cites this paper
• Role of Inflammation and Oxidative Stress Mediators in Gliomas

  2010cites this paper